Subcutaneous fat predicts bone metastasis in breast cancer: A novel multimodality-based deep learning model

Abstract

OBJECTIVES: This study explores a deep learning (DL) approach to predicting bone metastases in breast cancer (BC) patients using clinical information, such as the fat index, and features like Computed Tomography (CT) images. METHODS: CT imaging data and clinical information were collected from 431 BC patients who underwent radical surgical resection at Harbin Medical University Cancer Hospital. The area of muscle and adipose tissue was obtained from CT images at the level of the eleventh thoracic vertebra. The corresponding histograms of oriented gradients (HOG) and local binary pattern (LBP) features were extracted from the CT images, and the network features were derived from the LBP and HOG features as well as the CT images through deep learning (DL). The combination of network features with clinical information was utilized to predict bone metastases in BC patients using the Gradient Boosting Decision Tree (GBDT) algorithm. Regularized Cox regression models were employed to identify independent prognostic factors for bone metastasis. RESULTS: The combination of clinical information and network features extracted from LBP features, HOG features, and CT images using a convolutional neural network (CNN) yielded the best performance, achieving an AUC of 0.922 (95% confidence interval [CI]: 0.843–0.964, P< 0.01). Regularized Cox regression results indicated that the subcutaneous fat index was an independent prognostic factor for bone metastasis in breast cancer (BC). CONCLUSION: Subcutaneous fat index could predict bone metastasis in BC patients. Deep learning multimodal algorithm demonstrates superior performance in assessing bone metastases in BC patients.

Preoperative pectoralis muscle index predicts recurrence and metastasis in early-stage non- small cell lung cancer patients

“…As a part of the human skeletal muscular system, the relationship between the pectoralis muscle and cancer has been widely concerned. Recently, studies have con rmed the relationship between PMI and distant metastasis-free survival (DFMS) of breast cancer patients [29]. However, most studies have focused on the relationship between PMI and lung cancer incidence, length of postoperative hospital stay, or overall survival [12-15, 30, 31], and have not explored DMFS and RFS in lung cancer patients.…”